Clinical Trials · NCT07076030

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Name: Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Petrelintide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Zealand Pharma
Enrollment: 39
Start date: Apr 2025
Locations: 1 site, Germany
Primary endpoint: AUCo-inf of petrelintide

View Petrelintide compound reference